Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNP-MRI and MRF in Cervical Cancer
NCT04951921Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of [1-13C]pyruvate in Cervical Cancer (CC), sponsored by Chang Gung Memorial Hospital. Primary endpoint: MRI size measurement of the primary tumor at 3 months. Started Jul 2021; status: completed.
02
Drugs
[1-13C]pyruvate
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04951921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951921.